STEPHANIE WILCOX: Open Payments
NPI 1952750374 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,783 in 93 payments from 19 companies in 2025. Trend: 2023 $1,024 · 2024 $1,614 · 2025 $1,783
Food & beverage: $1,783
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $287 |
| PFIZER INC. | 15 | $279 |
| Novo Nordisk Inc | 12 | $217 |
| AstraZeneca Pharmaceuticals LP | 9 | $204 |
| Lilly USA, LLC | 7 | $125 |
| Corcept Therapeutics | 5 | $93 |
| Amgen Inc. | 5 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $50 |
Products named: VRAYLAR, NURTEC ODT, MOUNJARO, REXULTI, Wegovy, PREVNAR 20, Korlym, OTEZLA.
Industry payments across GA — which companies pay providers there.
